These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; Müller W Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589 [TBL] [Abstract][Full Text] [Related]
4. Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis: the effect on lymphocytes. Lacki JK; Leszczynski P; Mackiewicz SH J Investig Allergol Clin Immunol; 1996; 6(4):232-6. PubMed ID: 8844499 [TBL] [Abstract][Full Text] [Related]
5. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448 [TBL] [Abstract][Full Text] [Related]
6. [The effect of immunosuppressive drugs on expression of surface antigens of lymphocytes in patients with rheumatoid arthritis]. Lacki JK; Mackiewicz SH Pol Arch Med Wewn; 1997 Feb; 97(2):134-43. PubMed ID: 9312762 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice. Huyan XH; Lin YP; Gao T; Chen RY; Fan YM Int Immunopharmacol; 2011 Sep; 11(9):1293-7. PubMed ID: 21530682 [TBL] [Abstract][Full Text] [Related]
8. Increased HLA-DR and CD44 antigen expression in the gut: evidence of extraarticular immunological activity in rheumatoid arthritis. Abuzakouk M; Feighery C; Kelleher D; O'Briain DS; Jones E; Weir D; Casey E; O'Farrelly C J Rheumatol; 1999 Sep; 26(9):1869-76. PubMed ID: 10493664 [TBL] [Abstract][Full Text] [Related]
9. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus]. Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620 [TBL] [Abstract][Full Text] [Related]
10. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis. Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581 [TBL] [Abstract][Full Text] [Related]
11. [Clinical profiles of circulating dendritic cell phenotype and lymphocyte subsets in patients chronically infected with HBV during lamivudine treatment]. Li HW; Wang HF; Wang FS; Jin B; Duan XZ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):43-6. PubMed ID: 16642218 [TBL] [Abstract][Full Text] [Related]
12. Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs. Lacki JK; Klama K; Samborski W; Mackiewicz S; Mackiewicz U; Muller W Mater Med Pol; 1995; 27(2):47-51. PubMed ID: 8935189 [TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
14. In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease. Dejaco C; Reinisch W; Lichtenberger C; Waldhoer T; Kuhn I; Tilg H; Gasche C J Investig Med; 2000 Nov; 48(6):449-56. PubMed ID: 11094868 [TBL] [Abstract][Full Text] [Related]
15. Subpopulations of the peripheral lymphocytes in the early clinical forms of Lyme disease. Zajkowska JM; Hermanowska-Szpakowicz T Med Sci Monit; 2000; 6(2):278-84. PubMed ID: 11208323 [TBL] [Abstract][Full Text] [Related]
16. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991 [TBL] [Abstract][Full Text] [Related]
17. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. Aeberli D; Seitz M; Jüni P; Villiger PM Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629 [TBL] [Abstract][Full Text] [Related]
18. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216 [TBL] [Abstract][Full Text] [Related]
19. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease. Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430 [TBL] [Abstract][Full Text] [Related]
20. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes. Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]